一、核心事件:报价终止公告诺和诺德于2025年11月8日正式确认,不会提出更高的报价来收购生物制药公司Metsera, Inc.。此举标志着其对Metsera为期一周的主动竞购进程的终结,也体现了公司对财务纪律和股东价值的一贯承诺。二、事件回顾:三轮报价步步升级本次收购事件始于2025年10月30日,诺和诺德向Metsera提交了未经邀约的收购提案,该提案被Metsera董事会认定为“优越提案”。...
Source Link一、核心事件:报价终止公告诺和诺德于2025年11月8日正式确认,不会提出更高的报价来收购生物制药公司Metsera, Inc.。此举标志着其对Metsera为期一周的主动竞购进程的终结,也体现了公司对财务纪律和股东价值的一贯承诺。二、事件回顾:三轮报价步步升级本次收购事件始于2025年10月30日,诺和诺德向Metsera提交了未经邀约的收购提案,该提案被Metsera董事会认定为“优越提案”。...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.